Business Development Forum Kickoff - Webinar
IHIF's new Business Development Forum will kick off with a webinar on October 21 from 10:30 - 11:30 am on, "Innovative Discovery Spaces Past, Present & Future – 3 Cases Studies”. Invitation and Registration information are being forwarded to Forum members.
Your company or organization must be an IHIF member to participate in Forum discussions. If you are already a member, please sign-up here to join the Business Development Forum. Not a member? Sign up today!
|
|
COVID Updates and all the latest additions to the IHIF COVID-19 Toolkit
|
|
'Mission of the century': 8,000 cargo jets needed to transport Covid-19 vaccines around the world, says IATA
Karla Cripps, CNN • Updated 10th September 2020
(CNN) — As global pharmaceutical companies race to complete their Covid-19 vaccine trials, the logistics that will be required to deliver them to all corners of the world are coming into focus -- and it will be a mission like no other.
According to the International Air Transport Association (IATA), providing a single dose of the vaccine to 7.8 billion people will require the use of 8,000 Boeing 747 cargo aircraft -- and planning needs to begin now.
|
|
FDA broadens probe into serious illness in AstraZeneca coronavirus vaccine study: report
The Food and Drug Administration (FDA) has reportedly broadened its investigation into a serious illness suffered by a patient participating in AstraZeneca's COVID-19 vaccine testing trials.
|
|
Indianapolis-based Hc1.com, which makes software that helps health care organizations interpret data to personalize care and control costs, said it thinks it has a solution that will help major U.S. colleges and universities control coronavirus outbreaks on campus.
|
|
Eli Lilly announced the results from a 1,000-person study sponsored by the U.S. National Institute of Allergy and Infectious Diseases.
|
|
State developing vaccine guidelines
(Source IBJ Daily 9/14) Indiana health officials are developing the criteria they will use to decide who is entitled to receive a coronavirus vaccine when one becomes available. Health Commissioner Dr. Kristina Box expects the supply of doses will be extremely limited once the federal government approves a vaccine for widespread human use—possibly just 10 million or 15 million doses for the 330 million people living in the United States, she said last week. If the vaccine is distributed to each state based on its share of the U.S. population, Indiana might receive only 300,000 doses initially for its 6.7 million residents, The (Northwest Indiana) Times reported. “Indiana is using a team of experts to ethically look at, and medically look at, those individuals that should receive this immunization first here in the state of Indiana,” Box said.
|
|
US officials released a report to Congress and a playbook outlining the government's plans to make COVID-19 vaccines free to all Americans through a vaccination campaign set to begin gradually in January or possibly late this year. Medical supply company McKesson would be the main vaccine distributor and vaccinations would occur in four phases, beginning with health care workers, older adults, and people with underlying health conditions.
|
|
The Challenges and Opportunities for Medical Technology Companies During a Pandemic
Most of the world’s medical community is focused on one emergency today: COVID-19. For medical technology companies not already focused on epidemiology, virology or immunology, COVID-19 has caused more than a few challenges. The coronavirus has upended most areas of life, from the health of individuals and communities to the health of the economy. Read More
|
|
FAST BioMedical Establishes World-Recognized Heart Failure Medical Advisory Board
FAST BioMedical, a late clinical-stage medical technology company, today announces establishing a Heart Failure Medical Advisory Board of world-recognized physicians, nurses and researchers. The Board will advise FAST's clinical development of measuring volume status to better treat heart failure patients. The board collectively has decades of experience in heart failure and cardiovascular patient care and have contributed to more than 1,300 peer-reviewed publications.
|
|
Lilly Launches New Open Innovation Challenge
Indianapolis-based Eli Lilly and Co. (NYSE: LLY) has launched a new, national open innovation challenge. The pharmaceutical company says the challenge calls on individuals and teams to find digital health solutions to support people living with inflammatory skin diseases such as atopic dermatitis.
|
|
IHIF and Ivy Tech Community College have enjoyed a long partnership, culminating in the creation of a Biotechnology Associates degree, designed to meet the customized workforce needs of many of our regional life sciences employers. Whether your company needs to provide customized training or wants to offer workers the opportunity to grow their skill sets, Ivy Tech is your workforce partner of choice. Learn More
Certificate Programs (available on-line)
For questions about Regulatory Affairs or Biotechnology Degree, please contact:
Sengyong Lee, Ph.D., Biotechnology Program Chair/Professor
|
|
Training Workers for Life Sciences Careers
A coalition of organizations in Monroe County has created an apprenticeship program designed to help find and train workers for southwest Indiana’s growing life sciences industry. The Biomanufacturing Technician Apprenticeship Program was developed by Hoosier Hills Career Center and Ivy Tech Community College in Bloomington. The area has witnessed explosive growth in the biosciences sector even before the COVID-19 pandemic.
|
|
LUNA Language Services Earns Certification for ISO 9001:2015 and ISO 17100 Standards
We're proud to announce our official certification to ISO 9001:2015 and ISO 17100. Our commitment to providing quality services and achieving customer satisfaction led us to pursue the highest standards in the industry.
|
|
Kelley joins IU Ventures Investment Committee
Mark R. Kelley, PhD, is the newest member of the IU Ventures Investment Committee. Kelley, a professor of pediatrics and cancer researcher at Indiana University School of Medicine, was appointed by Jay L. Hess, MD, PhD, MHSA, dean of IU School of Medicine and IU Ventures board member. Kelley succeeds Distinguished Professor Emeritus Mervin Yoder, MD, who served on the committee from 2014 to 2020.
|
|
IU Researcher Lands Prestigious NIH Award
The National Institutes of Health has awarded a $2.3 million grant to Indiana University Assistant Professor Feng Guo, who is one of only 33 people in the country to receive the NIH Director's New Innovator Award. The university says the funding will be used to advance Guo's research on autoimmune diseases.
|
|
Ten Saint Mary’s student workers will be hired to work as analysts and startup coaches at the IDEA Center and will be involved every step of the way in the commercialization process.
|
|
IU School of Medicine Alzheimer's Program Awarded $1M
The Indiana University School of Medicine has received $1.3 million from the U.S. Department of Health and Human Services to launch a statewide Alzheimer’s Disease Programs Initiative. The three-year program intends to enhance, strengthen and support people with Alzheimer’s disease and related dementias.
|
|
Update from Cellexus
Here's an interview with Dr. Manuel Garrido, Production Specialist at TechnoPhage, on how they've scaled their phage manufacturing with the Cellexus CellMaker.
|
|
Catalent Expanding Again in Bloomington
New Jersey-based Catalent Inc. (NYSE: CTLT) is once again adding to its operations in Monroe County. The company is investing $14 million to acquire a facility in Bloomington it says will be used for early-phase clinical biologics formulation development and drug product fill and finish services.
|
|
A team of researchers from the University of Notre Dame, Johns Hopkins University, Ohio State University and the University of Florida has identified networks of genes that regulate the process responsible for determining whether neurons will regenerate in certain animals, such as zebrafish.
|
|
Orgenesis has struck a deal to acquire Koligo Therapeutics. The takeover will give Orgenesis control of an autologous cell therapy treatment for respiratory disease caused by COVID-19.
|
|
 |
Welcome New IHIF Members! |
|
|
|
Follow IHIF on Twitter to keep up with all of the latest news, events, and exclusive member benefits!
|
Koligo Therapeutics, Inc. is a regenerative medicine company dedicated to the commercialization and development of transformative cell therapies for pancreatic diseases. Koligo’s principal commercial product is KYSLECEL™ for chronic and acute recurrent pancreatitis. Koligo’s technology platform aims to improve cell and tissue transplant in multiple therapeutic areas including through the use of 3D bioprinting.
|
|
|
|
IHIF's Policy Corner
What We're Following at Home and on the Hill
-
Find your legislators and keep up with IHIF's advocacy efforts - here
|
|
New Voter Registration Tool - Biotech Votes 2020
Science is the way out of this pandemic and voting is the way you can help.
With Biotech Votes 2020, you can:
1) VERIFY polling/mail-in ballot information
2) REGISTER to vote
3) LEARN about the candidates & key biotech policies
Your voice is critical!
|
|
-
U.S. Chamber Calls Executive Orders on Drug Pricing ‘Flawed and Dangerous Policy’ Coming at ‘the Worst Possible Time’ - “The extent of U.S. leadership in bio-pharmaceutical research and development has never been more evident or important than in the COVID-19 pandemic. Importing price controls from foreign countries is flawed and dangerous policy that will result in a substantial reduction in investment in new cures and drugs at the worst possible time. We are all relying on America’s pharmaceutical innovators at this critical time.” – Neil Bradley, Executive Vice President and Chief Policy Officer, U.S. Chamber of Commerce
-
PhRMA Statement on Most Favored Nation Executive Order – ““PhRMA is committed to working with all stakeholders, including elected officials across the ideological spectrum, to find market-based, competitive reforms to the challenges facing our health care system and patients. The focus of any reforms must be on lowering costs for patients, ensuring patients’ access to medicines, addressing the misaligned incentives in the pharmaceutical supply chain and protecting the critical work being done to end COVID-19. Unfortunately, instead of pursuing these reforms the White House has doubled down on a reckless attack on the very companies working around the clock to beat COVID-19.”
|
|
Venture Summit\Virtual Connect 3
IHIF is pleased to invite you to attend Venture Summit \ Virtual Connect
Venture Summit \ Virtual Connect 3
Where Innovation Meets Capital
November 17-19, 2020
Come meet, interact and network online with more than 1,300 VCs, Corporate VCs, angel investors, industry execs and founders of venture backed, emerging and early stage Lifesciences/healthcare companies at the prestigious Venture Summit Virtual Connect 3 being held virtually on November 17th-19th 2020, featuring a dedicated Lifesciences/ Healthcare Track.
Whether you’re a Lifesciences/Healthcare startup seeking capital and exposure, or an investor seeking new deals, Venture Summit Virtual Connect 3.0 presented by youngStartup Ventures – is the event of the year you won’t want to miss.
A highly productive venture conference, Venture Summit Virtual Connect 3.0 is dedicated to showcasing VCs, Corporate VCs and angel investors committed to funding venture backed, emerging and early stage Lifesciences/Healthcare companies.
Special Offer:
IHIF has made special arrangement for our network to receive a special discount of 20% off the existing “early bird” savings. This conference will be attended by the best people in the industry. Please register early to avoid disappointment.
Register Today & Save - Click here. (Use promo code “IHIFVIP”)
|
|
This year's The MedTech Conference, originally set to be held in Toronto, will take place on a virtual platform with the 2022 conference to be held in Toronto. "The theme of this year's conference -- United by Purpose -- has never been more appropriate. While we may be unable to meet in person in Toronto, the show will go on! We'll have all the great opportunities our attendees have come to expect to connect and learn about the key issues that affect our industry," said AdvaMed President and CEO Scott Whitaker.
The Virtual MedTech Conference will bring together the world's top medtech executives and innovators to network, conduct business, gain access to capital and share insights in an engaging digital environment.
IHIF Member discount available. Save 10% on current registration fees.
|
|
BIO Investor Forum Digital starts next week - will you join us?
Register now to join the industry’s leading biopharma executives and BD professionals from public and venture-stage growth companies, and top public and private equity investment firms to explore potential partnerships and business collaborations that fuel research and development for promising innovation.
|
|
BioCrossroads Indiana Life Sciences Summit 2020
This year we will focus on COVID-19's impact on our life sciences companies and research institutions, and will highlight the critical role Indiana’s life sciences ecosystem has played in fighting the global health crisis. Don't miss the conversation!
Registration, schedule, and sponsorship details are now live!
|
|
IBJ Virtual Life Science Power Breakfast
Date: Friday, October 9, 2020 - 8:30 am
Cost: Individual Tickets & Corporate Rooms
RSVP by October 7, 2020
Featured Panelists:
-
Richard DiMarchi, PhD, Distinguished Professor of Chemistry, Linda & Jack Gill Chair in Biomolecular Sciences, Indiana University
-
Fritz French, Chairman, On Target Laboratories, Inc.
-
Rob Lyles, President, COOK Regentec, Vice President, COOK Group
-
Patricia Martin, President & CEO, BioCrossroads
-
Todd Saxton, Associate Professor, Strategy & Entrepreneurship, Indiana Venture Faculty Fellow, IU Kelley School of Business, Vice President of Business Development, Regenstrief Institute, Co-author, The Titanic Effect
Moderated By: John Russell, Health Care & Life Sciences Reporter, Indianapolis
Business Journal
|
|
Announcing the 2020 - 2021 IN Life Sciences Collaboration Conference Series!
Since 2006, CBLS has been presenting the Indiana Life Sciences Collaboration Conference Series, providing a forum for professionals in healthcare and life sciences to consider, discuss, and debate key business strategy issues. The conferences bring together leaders from industry, academia, government, and economic development communities. Join us in exploring business solutions and making new connections in the life sciences.
NEW FOR THIS YEAR....
This year's series will begin virtually, building upon great subjects and quality presenters just as in previous years. The November format is modified for a half-day schedule over a two day span. We are excited to leverage the highly ranked Kelley School of Business' online learning resources for educational and networking opportunities for the series!
Digital Health: Telehealth & Virtual Clinical Trials
November 12/13, 2020
Virtual
Advances in Behavioral/Mental Health Treatments
February 19, 2021
Virtual
Lessons Learned from the Pandemic
April 30, 2021
Format TBD
|
|
WishBone Medical Commits to Warsaw
Warsaw-based orthopedics device manufacturer WishBone Medical Inc. has announced plans to grow its global headquarters in Kosciusko County to allow for new product development and manufacturing. The company says it will also add more than 50 new jobs over the next two years.
|
|
Butler Professor Awarded Cancer Research Grant
Butler Professor Chioniso Masamha has her next five years of work planned out after receiving a National Institutes of Health grant for more than $1.3 million. Dr. Masamha will study the ways cancer cells multiply to hopefully lead to more strategies to detect and treat the disease.
|
|
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has posted new guidance regarding medical devices placed on the market in Great Britain (and Northern Ireland and European Union (EU)) starting January 1, 2021. This is of course in the event of an anticipated hard Brexit.
|
|
The COVID-19 pandemic is an overdue reminder for the US government to bring back medical manufacturing in the country, FDA Commissioner Stephen Hahn and Deputy Commissioner for Medical and Scientific Affairs Anand Shah write in an opinion piece. The consequences of the country's heavy reliance on foreign firms have been evident during the pandemic, from the fast depletion of the strategic national stockpile to shortages of medical supplies and drugs, but the government can take steps to address this crisis by incentivizing manufacturers to return to the US and investing in novel technologies that can address acute spikes in demand during emergency situations, among other steps, they wrote.
|
|
New Cold Storage Facility Planned for Whitestown
Texas-based Life Science Logistics has announced plans to build a third cold-chain storage distribution facility in central Indiana due to high demand for more pharmaceutical and medical device warehouse space.
|
|
B Medical Systems Opens US Subsidiary in Indiana
B Medical Systems, a leading European medical refrigeration and global vaccine cold chain manufacturer, is pleased to announce the official opening of its new 10,000 sq ft sales office and warehouse in Noblesville, Indiana. With over 40 years of experience in the medical refrigeration and vaccine cold chain market, the company offers a full line of medical-grade refrigerators, freezers, ultra-low temperature freezers, and transport devices designed for the safe storage and transport of biological materials, critical samples, blood, and vaccines.
|
|
Learn more about the NCI SBIR Contract Solicitation
We invite cancer technology innovators to submit proposals for the 2021 NCI SBIR Contract Solicitation. This year’s contract solicitation includes 17 topics proposed by the institute.
|
|
BIO Business Solutions provides cost-savings offers to eligible IHIF Members. To learn more about the programs and services available, please click here. Not an IHIF member? Join today! See the latest deals and offers from our BIO Business Solutions partners here
|
|
BIO Business Solutions® and IHIF have selected Chubb as its endorsed insurer due to their total insurance solutions for risks specific to life science companies. For more than 25 years, Chubb has been providing cost-effective risk management and insurance protection tailored to the unique needs of biotechnology companies. Chubb's products include property and casualty, product liability, clinical trial liability, errors and omissions liability, professional liability, and cyber liability insurance. Chubb personnel specialize in the biotech market; they understand the issues and develop tailored solutions. |
|
IHIF Member Benefits
Property and Casualty Insurance:
- Competitive premiums for companies at all stages
- Low minimum premiums for early stage companies
- Dedicated loss control and claims specialists for members
- Access to proprietary tools to assist in developing insurance values
Clinical Trials, Errors and Omissions, Product, and Professional Liability Insurance:
- 10% premium credit (subject to regulatory limitations)
|
|
About IHIF Membership
Now is a great time to become a member of the Indiana Health Industry Forum! Join your voice to over 150 current member companies to impact the strategic direction of Indiana's health science sector.
Membership in IHIF offers a number of solutions:
- Promote your business, locally, nationally, and globally.
- Support the industry in the state and contribute directly to its growth and direction.
- Find others who share your interests and build your business network.
- Lend your voice to public policies that support innovation.
- Directly impact your bottom line with significant savings and discount programs exclusively for IHIF members.
To complete a membership application, click here.
|
|
|
|
|
|
|
